Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ

Radiology

Volumn 201, Issue 2, 1996, Pages 427-432

  Soderstrom, Charles E ^a   Harms, Steven E ^a,b   Copit, Debra S ^a   Evans, Walter P ^a   Savino, Daniel A ^a   Krakos, Patricia A ^a   Farrell Jr , Robert S ^a   Flamig, Duane P ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Breast neoplasms, calcification; Breast neoplasms, diagnosis; Breast neoplasms, MR; Breast neoplasms, radiography; Magnetic resonance (MR), pulse sequences

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING;

EID: 0029858924     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.201.2.8888235     Document Type: Article

References (28)

1. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501.
2. Orel SG, Schnall MD, Li Voisi VA, Thoupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-493.
3. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171:95-103.
4. Heywang-Koebrunner SH, Viehweg P. Sensitivity of contrast-enhanced MR imaging of the breast. MR Imaging Clin North Am 1994; 2:527-538.
5. Lewis-Jones HG, Whitehouse GH, Leinster SE. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol 1991; 43:197-204.
6. Rubens D, Totterman S, Chako AK, et al. Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast. AJR 1991; 157:267-270.
7. Merchant TE, Thelissen GR, Kievit HC, Oosterwaal LJ, Bakker CJ, de Graaf PW. Breast disease evaluation with fat-suppressed magnetic resonance imaging. Magn Reson Imaging 1992; 10:335-340.
8. Stelling CB, Runge VM, Davey DD, et al. Dynamic enhancement of breast MRI at 30 seconds improved discrimination of sclerosing adenosis from invasive breast cancer (abstr). JMRI 1994; 4:90.
9. Boetes C, Mus RDM, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995; 197:743-747.
10. Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995; 196:415-419.
11. Frykberg ER, Bland KI. Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 1994; 74:350-361.
12. Holland R, Veling SHJ, Mravunac M, Hendriks JHCL. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 1985; 56:979-990.
13. Frykberg ER, Bland KI. In situ breast carcinoma. Adv Surg 1993; 26:29-72.
14. Neilsen M, Jensen J, Andersen JA. Precancerous and cancerous breast lesions during lifetime and at autopsy: a study of 83 women. Cancer 1984; 54:612-615.
15. Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg 1980; 192:139-147.
16. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6) 1: intraductal carcinoma (DCIS). Cancer 1986; 57:197-208.
17. Simpson T, Thirlby RC, Dail DH. Surgical treatment of ductal carcinoma in situ of the breast: 10- to 20-year follow-up. Arch Surg 1992; 127:468-472.
18. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63:618-624.
19. Baird RM, Worth A, Hislop G. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am J Surg 1990; 159:479-481.
20. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 1992; 70:2468-2474.
21. Page DL, DuPont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982; 49:751-758.
22. Gallagher WJ, Koerner FC, Wood WC. Treatment of intraductal carcinoma with limited surgery: long-term follow-up. J Clin Oncol 1989; 7:376-380.
23. Temple WJ, Jenkins M, Alexander F, et al. Natural history of in situ breast cancer in a defined population. Ann Surg 1989; 210: 653-657.
24. Arnesson LG, Smeds S, Fagerberg G, Grontoft O. Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br J Surg 1989; 76:672-675.
25. Carpenter R, Boulter PS, Cooke T, Gibbs NM. Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 1989; 76:564-567.
26. Price P, Sinnett HD, Gusterson B, Walsh G, A'Hern RP, McKinna JA. Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone. Br J Cancer 1990; 61:869-872.
27. Lewis D, Geschickter CF. Comedo carcinoma of the breast. Arch Surg 1938; 36:225-244.
28. Schnitt SJ. In situ carcinoma. In: Harris JR, Hellman S, Henderson IC, Kinne DW, eds. Breast diseases. 2nd ed. Philadelphia, Pa: Lippincott, 1991; 229-232.